CTLA4 and central nervous system cancer: The critical roles of CTLA-4 in regulating immunosuppressive antitumor responses have been illustrated in glioma, which suggest that anti-CTLA-4 treatment will largely enhance CD4+ T-cell proliferation and restore the Treg/CD4+ ratio to further support the antitumor response (171).